Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cbd Life Sciences Inc CBDL



OTCPK:CBDL - Post by User

Post by AveragePennyon Oct 31, 2024 8:25am
32 Views
Post# 36290251

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom

CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom

Projected to reach the $20 billion global mushroom market by 2030, CBDL's entry offers shareholders a unique opportunity to capitalize on a sector growing at over 14% annually

SCOTTSDALE, AZ / ACCESSWIRE / October 31, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) sets a new industry standard with its launch of a high-performance line of mushroom-infused gummies, designed to meet the surging demand for wellness products in a projected $20 billion market. Focused on energy, sleep, and sexual wellness, these unique formulations offer CBDL shareholders and new investors an unprecedented growth opportunity in an exploding sector.

https://www.accesswire.com/937211/cbd-life-sciences-inc-cbdl-launches-high-demand-mushroom-gummy-line-for-targeted-wellness-needs-tapping-into-a-booming-20-billion-market

<< Previous
Bullboard Posts
Next >>